BSECorp. Action7h ago · 25 Sept 2026, 11:25 am

Intimation of Record Date for Rights Issue

Natco Pharma Ltd · 524816

✦ AI SummaryFundraise

Natco Pharma Ltd has announced the record date for its rights issue, set as Thursday, 1st October, 2026, to determine the shareholders eligible to receive the rights entitlements.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Natco Pharma Ltd - 524816 - Intimation Of Record Date For Rights Issue

Attachments (1)

📄

ed4dcbeb-1059-409d-b096-2739a4b87033.pdf

pdf

Download →
View document text
September 25, 2026 Corporate Relationship Department The Manager – Listing M/s. BSE Ltd. M/s. National Stock Exchange of India Ltd. Mumbai – 400 001. MUMBAI – 400 051. Scrip Code: 524816 Scrip Code: NATCOPHARM Sub:- Intimation of record date pursuant to Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Ref: Outcome of the Board meeting intimated vide letter dated September 25, 2026 Dear Sir/Madam, Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at their meeting held today has fixed the Record date for the Rights Issue of the equity shares as Thursday, 1st October, 2026 to determine the shareholders who will be eligible to receive the Rights Entitlements under the Rights Issue. Kindly take the same on record. Thanking you Yours faithfully, For NATCO Pharma Limited Ch. Venkat Ramesh Company Secretary & Compliance Officer